Global COVID-19 Nucleic Acid Detection Kit Market Growth 2023-2029

Global COVID-19 Nucleic Acid Detection Kit Market Growth 2023-2029

During the test, it is only necessary to collect the patient's nasal and throat swabs and other secretion samples. Within 1.5 hours, 6 common respiratory viruses, including the new coronavirus, can be detected at one time, which not only helps medical staff to quickly distinguish between normal and normal people. Novel coronavirus infection can also effectively identify influenza patients and new coronary pneumonia patients, so as to achieve accurate diagnosis and subsequent accurate treatment of patients.

LPI (LP Information)' newest research report, the “COVID-19 Nucleic Acid Detection Kit Industry Forecast” looks at past sales and reviews total world COVID-19 Nucleic Acid Detection Kit sales in 2022, providing a comprehensive analysis by region and market sector of projected COVID-19 Nucleic Acid Detection Kit sales for 2023 through 2029. With COVID-19 Nucleic Acid Detection Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world COVID-19 Nucleic Acid Detection Kit industry.

This Insight Report provides a comprehensive analysis of the global COVID-19 Nucleic Acid Detection Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on COVID-19 Nucleic Acid Detection Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global COVID-19 Nucleic Acid Detection Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for COVID-19 Nucleic Acid Detection Kit and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global COVID-19 Nucleic Acid Detection Kit.

The global COVID-19 Nucleic Acid Detection Kit market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for COVID-19 Nucleic Acid Detection Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for COVID-19 Nucleic Acid Detection Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for COVID-19 Nucleic Acid Detection Kit is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key COVID-19 Nucleic Acid Detection Kit players cover PerkinElmer, Shanghai Sidi Biomedical Technology, Jiangsu Weidi Biomedical Technology, CapitalBio Corporation, Shenzhen Zijian Biotechnology, Sun Yat-Sen University Daan Gene, Shanghai Berger Medical Technology, Shanghai Zhijiang Biotechnology and Shengxiang Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 Nucleic Acid Detection Kit market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Fluorescent PCR Method
Colloidal Gold Method
Magnetic Particle Chemiluminescence

Segmentation by application
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
PerkinElmer
Shanghai Sidi Biomedical Technology
Jiangsu Weidi Biomedical Technology
CapitalBio Corporation
Shenzhen Zijian Biotechnology
Sun Yat-Sen University Daan Gene
Shanghai Berger Medical Technology
Shanghai Zhijiang Biotechnology
Shengxiang Biotechnology
Yaneng Biotechnology Shenzhen
BGI Wuhan
Guangzhou Wanfu Biotechnology
Zhuhai Livzon Reagent
Guangdong Hexin Health Technology
Innotek (Tangshan) Biotechnology
Mike Bio
Wuhan Mingde Biotechnology

Key Questions Addressed in this Report

What is the 10-year outlook for the global COVID-19 Nucleic Acid Detection Kit market?

What factors are driving COVID-19 Nucleic Acid Detection Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do COVID-19 Nucleic Acid Detection Kit market opportunities vary by end market size?

How does COVID-19 Nucleic Acid Detection Kit break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.